Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin
- PMID: 7011532
Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin
Abstract
We have studied the M5076 tumor, a transplantable murine reticulum cell sarcoma that arose spontaneously in the ovary of a C57BL/6 mouse. This tumor displays functional and ultrastructural characteristics indicating that it is of macrophage origin. Cells from the M5076 tumor are phagocytic, form rosettes with sheep red blood cells, mediate antibody-dependent cellular cytotoxicity against 51Cr-labeled red blood cells, and display macrophage-like cytotoxicity against syngeneic tumor target cells but do not exhibit any natural killer cell activity. The tumor cells possess lysozyme, nonspecific esterase, and phosphatase activities comparable to that seen in rodent macrophages. Ultrastructural examination revealed phagocytic vacuoles and a lack of tight junctions typical of macrophage morphology. Karyotype analysis showed that M5076 tumor cells are hypodiploid with a high percentage (greater than 80%) of metacentric chromosomes that serve as an excellent marker for identification of these tumor cells.
Similar articles
-
Development and characterization of a rat histiocyte-macrophage tumor line.J Natl Cancer Inst. 1986 May;76(5):871-8. J Natl Cancer Inst. 1986. PMID: 3457975
-
Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.J Immunol. 1975 Feb;114(2 pt 2):898-905. J Immunol. 1975. PMID: 1089721
-
Inhibition of cellular division of a murine macrophage tumor by macrophage-activating agents.Cancer Res. 1982 May;42(5):1850-5. Cancer Res. 1982. PMID: 7039820
-
Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth.Cancer Res. 1981 Apr;41(4):1281-7. Cancer Res. 1981. PMID: 7011533
-
Inhibited growth of a reticulum cell sarcoma (M5076) induced in vitro and in vivo by macrophage-activating agents.Cancer Res. 1984 Jun;44(6):2446-51. Cancer Res. 1984. PMID: 6372993
Cited by
-
Antitumor activity and mechanism of action of the marine compound girodazole.Invest New Drugs. 1991 Aug;9(3):233-44. doi: 10.1007/BF00176976. Invest New Drugs. 1991. PMID: 1783523
-
On the origin of cancer metastasis.Crit Rev Oncog. 2013;18(1-2):43-73. doi: 10.1615/critrevoncog.v18.i1-2.40. Crit Rev Oncog. 2013. PMID: 23237552 Free PMC article. Review.
-
The selective nature of metastasis.Cancer Metastasis Rev. 1983;2(1):25-40. doi: 10.1007/BF00046904. Cancer Metastasis Rev. 1983. PMID: 6616441
-
Developing new drugs for ovarian cancer: a challenging task in a changing reality.J Cancer Res Clin Oncol. 1984;107(2):111-24. doi: 10.1007/BF00399382. J Cancer Res Clin Oncol. 1984. PMID: 6371015 Free PMC article. Review.
-
Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice.Cancer Chemother Pharmacol. 1990;26(2):122-6. doi: 10.1007/BF02897257. Cancer Chemother Pharmacol. 1990. PMID: 2189589
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials